PGI Developed ABC Device To Compete With Ventilator

Chandigarh: In the Bio Medical Instruments and Device Lab of Chandigarh PGI, the institute’s experts have developed a device that is giving tough competition to ventilators. It has been named Artificial Breathing Capability Device (ABCD). After the completion of the clinical trial of the device and getting the patent.

The institute is now preparing to launch it in the market in collaboration with a private company. Dr. Joseph L. Mathew, in-charge of Bio Medical Instruments and Device Lab and Advanced Pediatric Center, said that this device is very effective. Work on it was started in 2018.

After the success of the clinical trial and patent, it has been given to a private company for manufacturing. It is expected that the device will be available in the market soon. The most special thing about this device is that it will cost 50 to 60 thousand rupees to make it, while a ventilator is purchased for 20 to 25 lakh rupees.

Dr. Mathew said that the device does not meet all the standards of a ventilator, but it includes all the necessary standards so that the life of a critical patient can be saved in an emergency.

After the arrival of this device, in case of lack of ventilator, the employee or the patient’s family will not need to press the ambu bag. Dr. Mathew said that the device has been equipped with an electro-mechanical system, with the help of which the machine can be given commands based on the sensor readings. It can be used for children and adults as well as for people suffering from serious lung diseases and in trauma cases. After setting the pressure, it has been connected to an alarm, so that in case of imbalance, information can be received immediately. Along with this, the alarm will ring even if the patient’s condition is critical.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit